Mediphage Bioceuticals Competitors and Similar CompaniesClear all

Mediphage Bioceuticals's competitors and similar companies include Ambrx and ProQR Therapeutics.
Mediphage Bioceuticals
Mediphage Bioceuticals
Mediphage Bioceuticals is a genetic medicine company developing a non-viral gene delivery vector platform.
Ambrx
Ambrx
Ambrx is a biopharmaceutical company that discovers and develops engineered precision biologics therapeutics using an expanded genetic code.
ProQR Therapeutics
ProQR Therapeutics
ProQR Therapeutics is a company that develops RNA therapies designed for patients suffering from genetic rare diseases.
Founding Date
Founding Date
2016
Founding Date
2003
Founding Date
2012
Type
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Toronto, CA HQ
Locations
San Diego, US HQ
Locations
Leiden, NL HQ
Cambridge, US
Employees
Employees
1023% decrease
Employees
70
Employees
166
Valuation ($)
Valuation ($)
N/A
Valuation ($)
1.8 b
Valuation ($)
281.8 m

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$7.4m (FY, 2022)
Revenue (est.)
€15.9m (FY, 2025)
Net income
Net income
N/A
Net income
($78m) (FY, 2022)
Net income
(€42.2m) (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 4.1m
Total funding raised
$ 347.9m
Total funding raised
$ 57.8m
For sources of this data, please see the company profile

View Company Profiles

Ambrx
HQ
San Diego, US
Employees
70

Ambrx is a biopharmaceutical company that discovers and develops engineered precision biologics therapeutics using an expanded genetic code.

View company
ProQR Therapeutics
HQ
Leiden, NL
Employees
166

ProQR Therapeutics is a company that develops RNA therapies designed for patients suffering from genetic rare diseases.

View company